ARMP ▼ -0.4% - Armata Pharmaceuticals, Inc. $ARMP ARMP ARMP ARMP - Armata Pharmaceuticals Announces New Publication That Advances Understanding of Phage Biology to Support Development of Next-Generation Antibacterials Armata Pharmaceuticals announced a new publication advancing the understanding of phage biology to support its next-generation antibacterial development, though the stock declined 0.4% today. The modest pullback suggests investors may have already priced in expectations around the company's research progress, or the market awaited more concrete clinical or commercial developments. 03-SEP-2026 07:01 AM ET